Literature DB >> 9349997

Usefulness of novel imaging modalities in diagnosis of focal nodular hyperplasia of the liver.

Y Nishigaki1, E Tomita, Y Matsuno, K Goto, T Ohnishi, Y Tanaka, H Iwai, H Asano, I Yasuda, K Nagura, T Wakahara, T Yamada.   

Abstract

A 17-year-old woman was admitted because of a liver tumor found incidentally by ultrasonography. Liver function was normal and there were no markers of hepatitis viruses or malignancy. Abdominal ultrasonography, computed tomography (CT), and magnetic resonance imaging revealed a mass (2 cm in diameter) in the lateral segment of the left lobe of the liver. The lesion was not detected by hepatic arteriography. However, dynamic CT with fast scanning and dynamic CO2-enhanced ultrasonography demonstrated initial central enhancement of the mass followed by centrifugal spread of enhancement to the periphery. Color Doppler flow imaging detected a central color spot, shown to be an artery by a pulsed Doppler spectrum analysis. Fine-needle biopsy confirmed a diagnosis of focal nodular hyperplasia. Dynamic CT with fast scanning, dynamic CO2-enhanced ultrasonography, and color Doppler flow imaging were useful in detecting the vascular pattern specific to focal nodular hyperplasia. Investigation of further cases with these novel imaging modalities should help to establish a comprehensive diagnostic procedure and thus avoid unnecessary surgery for focal nodular hyperplasia, which is a completely benign lesion.

Entities:  

Mesh:

Year:  1997        PMID: 9349997     DOI: 10.1007/bf02934121

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  34 in total

1.  Hepatic cell adenomas, spontaneous liver rupture, and oral contraceptives.

Authors:  J A Ameriks; N W Thompson; C F Frey; H D Appelman; J F Walter
Journal:  Arch Surg       Date:  1975-05

Review 2.  Benign liver tumors.

Authors:  F C Nichols; J A van Heerden; L H Weiland
Journal:  Surg Clin North Am       Date:  1989-04       Impact factor: 2.741

3.  Focal liver masses: differential diagnosis with pulsed Doppler US.

Authors:  K J Taylor; I Ramos; S S Morse; K L Fortune; L Hammers; C R Taylor
Journal:  Radiology       Date:  1987-09       Impact factor: 11.105

4.  Hepatic adenoma and focal nodular hyperplasia: a diagnostic dilemma.

Authors:  V Low; M S Khangure
Journal:  Australas Radiol       Date:  1990-05

5.  Focal nodular hyperplasia of the liver: results of treatment and options in management.

Authors:  J A Pain; A E Gimson; R Williams; E R Howard
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

6.  Central scars in primary liver tumors: MR features, specificity, and pathologic correlation.

Authors:  E Rummeny; R Weissleder; S Sironi; D D Stark; C C Comptom; P F Hahn; S Saini; J Wittenberg; J T Ferrucci
Journal:  Radiology       Date:  1989-05       Impact factor: 11.105

7.  Focal nodular hyperplasia of the liver: arterial angio-CT and microangiography.

Authors:  K Takayasu; Y Muramatsu; N Moriyama; S Yamazaki; T Takayama; S Hirohashi; Y Shimamura; A Takahashi
Journal:  J Comput Assist Tomogr       Date:  1992 Mar-Apr       Impact factor: 1.826

Review 8.  Hepatic adenoma and focal nodular hyperplasia.

Authors:  C K Shortell; S I Schwartz
Journal:  Surg Gynecol Obstet       Date:  1991-11

9.  Resection of presumed benign liver tumours.

Authors:  J Belghiti; D Pateron; Y Panis; V Vilgrain; J F Fléjou; J P Benhamou; F Fékété
Journal:  Br J Surg       Date:  1993-03       Impact factor: 6.939

10.  Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.

Authors:  I A Koelma; M Nap; S Huitema; R A Krom; H J Houthoff
Journal:  Arch Pathol Lab Med       Date:  1986-11       Impact factor: 5.534

View more
  1 in total

1.  Thyroid and Hepatic Haemodynamic Alterations among Egyptian Children with Liver Cirrhosis.

Authors:  Zeinab A El-Kabbany; Rasha T Hamza; Ahmed S Abd El Hakim; Lamis M Tawfik
Journal:  ISRN Gastroenterol       Date:  2012-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.